信息更新：
大家新年好！好久没来更新了，确实也是因为没有进展消息，下面是2013年2月6日的邮件信息里面提到HerpV的信息，里面提到数据结果要到2013年第四季度才能发布，也就是说5月份应该不会发布信息，要等到今年10月~12月之间才能发布第二阶段的研究结果了。大家还是要有耐心！
下面是邮件对HerpV描述的原文：
Heat Shock Protein Platform: Recombinant Series HerpV
HerpV is the most advanced HSV-2 therapeutic vaccine currently in clinical development for the treatment of genital herpes. A Phase 2 study measuring the effect of vaccination on viral shedding in individuals infected with HSV-2 is underway. Data results for this study are anticipated in Q4’13. Experts in HSV-2 clinical research believe that a reduction in viral shedding could translate into the clinical benefit of a reduction in recurrent outbreaks.
